ProQR Therapeutics N.V. buy Raymond James
Start price
08.11.23
/
50%
€1.27
Target price
08.11.24
€3.75
Performance (%)
25.12%
Price
10.07.24
€1.58
Summary
This prediction is currently active. The prediction currently has a performance of 25.12%. This prediction currently runs until 08.11.24. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
ProQR Therapeutics N.V. | 1.279% | 1.279% |
iShares Core DAX® | 0.443% | 0.771% |
iShares Nasdaq 100 | -0.150% | 4.094% |
iShares Nikkei 225® | 2.566% | 4.202% |
iShares S&P 500 | 0.479% | 2.881% |
Comments by Raymond_James for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its price target lowered by analysts at Raymond James from $5.00 to $4.00. They now have an "outperform" rating on the stock.
Ratings data for PRQR provided by MarketBeat